for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
PharmAsia News
   Journal TOC RSS feeds Export to Zotero Follow    
   Full-text available via subscription Subscription journal
     ISSN (Print) 1875-7774
     Published by Informa plc Homepage  [13 journals]
  • Major CSPC Pharma Stakeholder Sells Second Chunk Of Shares
    • Abstract: A major China investor in Hong Kong's CSPC Pharmaceutical Group plans to sell another chunk of shares worth up to $535 million, the second such sale in the past three months.
      PubDate: Fri, 29 Aug 2014 06:00:13 -040
       
  • China Research Sustains Hepatitis C Virus In Lab Mouse
    • Abstract: China researchers say they have been able to inject a laboratory mouse with the chronic hepatitis C virus, making it possible for the first time to test its effect without initial trials on humans or chimpanzees.
      PubDate: Fri, 29 Aug 2014 06:00:09 -040
       
  • Meiji Seika Pharma Acquisition Of Medreich Cleared By CCI
    • Abstract: Meiji Seika Pharma's acquisition of Medreich has been cleared by the Competition Commission of India after concluding the merger would not have an adverse impact on competition.
      PubDate: Fri, 29 Aug 2014 06:00:00 -040
       
  • Takeda Forecasts 20% Annual Profit Growth Over Three Years
    • Abstract: Takeda Pharmaceuticals expects to register an annual profit growth of at least 20% over the next three years by raising its core earnings by 80% to just over $4.8 billion by 2017.
      PubDate: Fri, 29 Aug 2014 02:30:00 -040
       
  • Takeda Fails To Overturn $9Bn Actos Punitive Damages
    • Abstract: A jury's assessment of $9 billion in punitive damages against Takeda Pharmaceuticals and its U.S. partner Eli Lilly will stand for now, following a U.S. district court judge ruling on a bid by the drug makers to have it overturned.
      PubDate: Fri, 29 Aug 2014 02:25:00 -040
       
  • Adcock Logs Loss After Acquisition Fight
    • Abstract: Adcock Ingram Holdings, caught in a takeover fight last year, said it had posted a nine-month loss because of business changes resulting from the battle.
      PubDate: Fri, 29 Aug 2014 02:20:01 -040
       
  • INTERVIEW: Novo Diving Deeper Into International Diabetes Tsunami
    • Abstract: Novo Nordisk, the Danish insulin specialist, is poised to take a big leap into its international business. As diabetes takes on alarming proportions in hundreds of developing markets, Novo is angling to further strengthen its presence.
      PubDate: Fri, 29 Aug 2014 00:05:02 -040
       
  • Emerging Markets Earnings Roundup: Novo Nordisk (Part 15)
    • Abstract: Novo Nordisk was hit by a strong Danish kroner in the second quarter, but has managed to keep costs in check in international sales efforts by reducing spending in the U.S. and Europe.
      PubDate: Fri, 29 Aug 2014 00:00:09 -040
       
  • China To Inject Billions Into Grassroots Health Services
    • Abstract: Seventy-three thousand hospital beds will be added and capacity for 54 million out-patient visits and 2.2 million hospital stays created under China’s latest health investment plan, while 18,000 physicians from urban hospitals will work alongside “barefoot doctors” in counties and towns.
      PubDate: Thu, 28 Aug 2014 21:30:01 -040
       
  • Indian Regulator Orders New Inquiry Into Sun-Ranbaxy Merger
    • Abstract: The Competition Commission of India has taken the unusual step of conducting an additional inquiry into the Sun Pharmaceutical Industries acquisition of Ranbaxy Laboratories, citing national interest concerns.
      PubDate: Thu, 28 Aug 2014 03:05:04 -040
       
  • Singapore Scientists Eye Cancer Drug For Leukemia
    • Abstract: Singapore researchers say they have discovered a new treatment for leukemia, an existing PARP inhibitor already used to treat cancer that resulted from DNA damage.
      PubDate: Thu, 28 Aug 2014 03:05:01 -040
       
  • OEP Philippines Orders Recall Of Angina Drug
    • Abstract: OEP Philippines has ordered a recall of batches of its Aprior (nicorandil) drug for treating angina after samples were found by the Italian Medicines Agency to have failed good manufacturing practice guidelines.
      PubDate: Thu, 28 Aug 2014 02:55:01 -040
       
  • Beijing Sets Out Medical Service Priorities
    • Abstract: The top priority of medical services reform in Beijing this year is the distribution of resources.
      PubDate: Thu, 28 Aug 2014 02:45:01 -040
       
  • China Issues Rural Health And Family Planning Anti-Poverty Plan
    • Abstract: China’s NHFPC announced a “Plan for Rural Health and Family Planning for Poverty Alleviation” on Aug. 21.
      PubDate: Thu, 28 Aug 2014 02:40:01 -040
       
  • NHFPC Publishes Diagnostic Standards For Ebola
    • Abstract: China’s NHFPC issued a notice of diagnostic criteria and treatment methods for ebola virus cases on Aug. 21, in which it expressly prescribed the criteria for cases to be classed as observed, suspected and confirmed.
      PubDate: Thu, 28 Aug 2014 02:30:01 -040
       
  • Chinese Agencies Jointly Promote Domestic Devices
    • Abstract: NHFPC and the Ministry of Industry jointly held a conference in Beijing on Aug. 16 to promote the development and application of domestic medical equipment.
      PubDate: Thu, 28 Aug 2014 02:25:00 -040
       
  • Piramal Trims Research To Build Companions Of Neuraceq
    • Abstract: Piramal Lifesciences has cut its research focus, eliminating drugs in the early stage development. Instead, the company will build on products that can be “companion products” to its newly launched flagship brand Neuraceq, used to detect symptoms associated with Alzheimer’s disease.
      PubDate: Thu, 28 Aug 2014 01:30:00 -040
       
  • Sanofi Off-Patent Brands In Deal Hunter Lupin’s Sights'
    • Abstract: Indian drug maker Lupin is openly scouting for global deals. While it is being seen as a possible bidder for some GSK generic brands, experts say the company may also be involved in examining several other similar transactions.
      PubDate: Thu, 28 Aug 2014 01:20:01 -040
       
  • Emerging Markets Regulatory Tracker: Brazil (Vol. 4 No. 53)
    • Abstract: Medical device manufacturers need to gear up for an e-submission format in Brazil that will be harmonized to a protocol outlined by the IMDRF.
      PubDate: Thu, 28 Aug 2014 00:45:00 -040
       
  • No Acquisition But Roche/Chugai Rejig Alliance Terms
    • Abstract: Despite rumors over the past few weeks that Roche is planning to fully buy out Chugai, this now looks less likely given reported resistance from the Swiss group's currently 62%-held Japanese affiliate and Roche's $8.3 billion acquisition of US firm InterMune.
      PubDate: Thu, 28 Aug 2014 00:20:00 -040
       
  • Nihon Chouzai: Japan Generic Volume Share Rising
    • Abstract: The volume usage of generic drugs in pharmacies around Japan has reached 70% of the substitutable market, according to information from Nihon Chouzai.
      PubDate: Wed, 27 Aug 2014 22:15:02 -040
       
  • FujiFilm Ready To Provide Unapproved Ebola Drug On WHO Request
    • Abstract: FujiFilm Holdings is ready to supply its unapproved Ebola hemorrhagic fever drug to African regions where the disease is spreading, should the WHO request it to do so.
      PubDate: Wed, 27 Aug 2014 22:10:00 -040
       
  • AnGes Plans Phase III Trials With Atopic Dermatitis Drug
    • Abstract: Japanese bioventure AnGes MG has progressed to Phase III trials with a new atopic dermatitis drug it is developing.
      PubDate: Wed, 27 Aug 2014 22:05:14 -040
       
  • Baxter Gets Japan Reimbursement For Hemostatic Agent Floseal
    • Abstract: Baxter has received confirmation that Floseal, a hemostatic agent used when normal hemostasis is not possible during surgery, will be covered by the national health insurance system in Japan.
      PubDate: Wed, 27 Aug 2014 22:00:01 -040
       
  • Astellas To Slash Japan Sales Offices By October
    • Abstract: Astellas has decided to reduce the number of its sales offices in Japan from 159 to 100 by Oct. 1.
      PubDate: Wed, 27 Aug 2014 21:55:00 -040
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014